Clinical Trial Update: Activated Protein C and Microcirculation

View source ↗

Summary

A completed clinical trial examining activated protein C and its effects on microcirculation in patients with severe sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Xigris (Drotrecogin alfa (activated))

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Severe Sepsis, Septic Shock | Status: COMPLETED